Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
p acnes corneal ulcer endopthalmitis kaposi esotropia intraocular uveitis optic neuritis anisocoria retinitisYour Article Summary
A new agent for the treatment of noninfectious uveitis: rationale and design of three LUMINATE (Lux Uveitis Multicenter Investigation of a New Approach to Treatment) trials of steroid-sparing voclosporin
Clinical Ophthalmology, 01/27/09
Anglade E et al. - The LUMINATE clinical development program was initiated in 2007 to assess the safety and efficacy of voclosporin for the treatment, maintenance, and control of all forms of noninfectious uveitis. If LUMINATE is successful, voclosporin will become the first Food and Drug Administration-approved corticosteroid-sparing agent for this condition.
Related Articles
Inflammatory mediators and posterior segment involvement in ocular Behcet disease
European Journal of Ophthalmology, 11/11/09
Relevance Score: 87%%
Seroprevalence of Bartonella henselae in patients with uveitis and healthy individuals in Tokyo
Japanese Journal of Ophthalmology, 11/10/09
Relevance Score: 87%%
Successful switching to adalimumab in an infliximab-allergic patient with severe Behcet disease-related uveitis
Rheumatology International, 11/02/09
Relevance Score: 85%%
The effect of clinical severity and eyelid rash on ocular involvement in primary varicella infection
European Journal of Ophthalmology, 11/05/09
Relevance Score: 84%%
IL-33 shifts macrophage polarization, promoting resistance against Pseudomonas aeruginosa keratitis
Investigative Ophthalmology and Visual Science, 11/23/09
Relevance Score: 80%%
Today in Uveitis...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approval for Uveitis Treatment for Sirion's Durezol
Review of Ophthalmology, 12/02/09
Intraocular antibody synthesis against rubella virus and other microorganisms in Fuchs heterochromic cyclitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 12/01/09
Role of neutrophils, MyD88-mediated neutrophil recruitment and complement in antibody-mediated defense against Pseudomonas aeruginosa keratitis
Investigative Ophthalmology and Visual Science, 12/01/09
Article Search
Sponsor


See Latest Articles


